ATH 25.0% 0.5¢ alterity therapeutics limited

Neuroprotective copper bis(thiosemicarbazonato) complexes...

  1. 1,494 Posts.
    lightbulb Created with Sketch. 93
    Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation.

    Bica L1, Liddell JR1, Donnelly PS2, Duncan C1, Caragounis A1, Volitakis I3, Paterson BM2, Cappai R4, Grubman A1, Camakaris J5, Crouch PJ6, White AR6.
    Author information

    • 1Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
    • 2Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia ; School of Chemistry, The University of Melbourne, Melbourne, Victoria, Australia.
    • 3Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
    • 4Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia ; Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
    • 5Department of Genetics, The University of Melbourne, Melbourne, Victoria, Australia.
    • 6Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia ; Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
    Abstract

    Abnormal biometal homeostasis is a central feature of many neurodegenerative disorders including Alzheimer's disease (AD), Parkinson's disease (PD), and motor neuron disease. Recent studies have shown that metal complexing compounds behaving as ionophores such as clioquinol and PBT2 have robust therapeutic activity in animal models of neurodegenerative disease; however, the mechanism of neuroprotective action remains unclear. These neuroprotective or neurogenerative processes may be related to the delivery or redistribution of biometals, such as copper and zinc, by metal ionophores. To investigate this further, we examined the effect of the bis(thiosemicarbazonato)-copper complex, Cu(II)(gtsm) on neuritogenesis and neurite elongation (neurogenerative outcomes) in PC12 neuronal-related cultures. We found that Cu(II)(gtsm) induced robust neurite elongation in PC12 cells when delivered at concentrations of 25 or 50 nM overnight. Analogous effects were observed with an alternative copper bis(thiosemicarbazonato) complex, Cu(II)(atsm), but at a higher concentration. Induction of neurite elongation by Cu(II)(gtsm) was restricted to neurites within the length range of 75-99 µm with a 2.3-fold increase in numbers of neurites in this length range with 50 nM Cu(II)(gtsm) treatment. The mechanism of neurogenerative action was investigated and revealed that Cu(II)(gtsm) inhibited cellular phosphatase activity. Treatment of cultures with 5 nM FK506 (calcineurin phosphatase inhibitor) resulted in analogous elongation of neurites compared to 50 nM Cu(II)(gtsm), suggesting a potential link between Cu(II)(gtsm)-mediated phosphatase inhibition and neurogenerative outcomes.
    PMID:
    24587210
    [PubMed - in process]
    PMCID:
    PMC3938583
    Free PMC Article
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $27.94K 6.050M

Buyers (Bids)

No. Vol. Price($)
47 58163299 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 57489001 48
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 20524121
Last updated 15.46pm 28/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.